A ‘first loop’ linear epitope accessible on native hepatitis B surface antigen that persists in the face of ‘second loop’ immune escape
- 1 February 2003
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 84 (2) , 269-275
- https://doi.org/10.1099/vir.0.18667-0
Abstract
Murine monoclonal antibodies (mAbs) were raised following immunization with native mutant hepatitis B surface antigen (HBsAg) purified from human sera. A set of antibodies binding to a linear epitope carried between residues 121 and 129 of the s region was demonstrated. These antibodies were shown by cross-competition assays to bind to a single epitope whose antigenicity was influenced by the TTP motif lying between residues 125 and 127. This first loop epitope remained accessible on the surface of HBsAg in spite of major second loop mutations abrogating the normal a conformational epitopes. The mAb and its binding region in the first loop are important diagnostically and may represent an importance immunological target, one that is stable in the face of immunologically driven escape.Keywords
This publication has 28 references indexed in Scilit:
- Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantationHepatology, 1998
- Hepatitis B virus surface mutations associated with infection after liver transplantationJournal of Hepatology, 1996
- Mutations of some critical amino acid residues in the hepatitis B virus surface antigenJournal of Medical Virology, 1995
- A novel hepatitis B virus variant in the sera of immunized childrenJournal of General Virology, 1994
- Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.Journal of Clinical Investigation, 1992
- Independent emergence of a vaccine-induced escape mutant of hepatitis B virusJournal of Hepatology, 1991
- Vaccine-induced escape mutant of hepatitis B virusThe Lancet, 1990
- Mutants of the hepatitis b virus surface antigen that define some antigenically essential residues in the immunodominant a regionJournal of Medical Virology, 1989
- AFFINITY OF ANTIBODY RESPONSES IN MAN TO HEPATITIS B VACCINE DETERMINED WITH SYNTHETIC PEPTIDESThe Lancet, 1984
- The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgMEpidemiology and Infection, 1982